Halozyme Therapeutics (HALO) Tops Q3 EPS by 5c; Offers FY23 Guidance
Go back to Halozyme Therapeutics (HALO) Tops Q3 EPS by 5c; Offers FY23 Guidance| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 101.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $101.79 | 52 Week High | $18.39 | |||
| Open | $101.79 | 52 Week Low | $6.96 | |||
| Day High | $101.79 | P/E | N/A | |||
| Day Low | $101.79 | EPS | $-0.58 | |||
| Volume | 525 | |||||
